– GERMANY, Berlin – Endel, a sound wellness company, today announced it has raised a $15 million Series B round led by Waverley Capital and True Ventures.…
– GERMANY, Hannover – Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr.…
– GERMANY, Dusseldorf – LenioBio GmbH, a German life sciences biotech offering a disruptive protein manufacturing technology, ALiCE, closed its Series-A Extension round with a total investment volume of €11.5 million.…
– GERMANY, Berlin – Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, today announced the appointment of Klaus-Günter Vennemann to its Board as Independent Director, effective February 1, 2022.…
– GERMANY, Rostock – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the nomination of Kim Stratton as CEO, transitioning from Interim CEO, effective immediately.…